Ivera Gets FDA 510(k) Clearance To Market Curos™ Port Protector, Medical Device Which Lowers Hospital Acquired Bloodstream Infection Exposure

Main Category: Bones / Orthopedics
Also Included In: Conferences
Article Date: 29 Oct 2008 - 10:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:2 stars

2 (1 votes)


Ivera Medical Corporation, a San Diego (CA) based medical device company today announced that it received FDA 510(k) clearance to begin marketing its Curos™ Port Protector, an innovative medical device that decontaminates needleless intravenous (I.V.) access ports, and helps to prevent touch and airborne contamination.

According to a recent study published by the Pennsylvania Health Care Cost Containment Council, the incidence and associated cost of hospital acquired bloodstream infections are increasing at an alarming rate. The Curos Port Protector is designed to reduce patient exposure to the risks of hospital acquired bloodstream infections and help maintain hospital infection control protocols.

"The Curos Port Protector market approval is a significant milestone toward the success of our company," Bob Rogers, Chief Executive Officer of Ivera Medical said. "It confirms our commitment to assist healthcare providers in their efforts to reduce bloodstream infections caused by touch or airborne contamination of needleless I.V. ports."

Hospital acquired bloodstream infections dramatically increase a patient's hospital length of stay, potential mortality and the overall cost of care, according to the Pennsylvania Health Care Cost Containment Council study. Every year in the United States alone, hospital acquired bloodstream infections are estimated to cost the healthcare system over $5 billion.

"At a time when our healthcare system is reducing reimbursements for the treatment of bloodstream infections, the Curos Port Protector will change infection control practices and help healthcare professionals improve patient care," Jack Saladow, Vice President of Marketing and Sales for Ivera Medical said.

About Ivera Medical Corporation

Ivera Medical develops, manufactures and markets innovative, high quality medical devices to improve healthcare providers' management and control of patient infections. Ivera Medical products are made in the USA.

Ivera Medical Corporation

Article adapted by Medical News Today from original press release.
Visit our bones / orthopedics section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Ivera Medical Corporation. "Ivera Gets FDA 510(k) Clearance To Market Curos™ Port Protector, Medical Device Which Lowers Hospital Acquired Bloodstream Infection Exposure." Medical News Today. MediLexicon, Intl., 29 Oct. 2008. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/127385.php>

APA
Ivera Medical Corporation. (2008, October 29). "Ivera Gets FDA 510(k) Clearance To Market Curos™ Port Protector, Medical Device Which Lowers Hospital Acquired Bloodstream Infection Exposure." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/127385.php.

Please note: If no author information is provided, the source is cited instead.




Bones / Orthopedics

Most Popular Articles



Follow Our Bones News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Bones / Orthopedics Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »